Horizon Vision Centers
Call Today: 800-921-2020

When it was approved in 2003 as the first new laser in five years, the FDA granted the ALLEGRETTO WAVE® the widest approval range ever initially given to a new laser for both myopic and hyperopic vision correction. Since then, the results have been astoundingly positive. On gaining FDA approval in 2006, the ALLEGRETTO WAVE® Eye-Q took this tradition of excellence another step forward, providing proven superior clinical results, as shown by the following statistics:

A great source for information about LASIK and questions to ask your physician is the FDA website and the website of the American Society of Cataract and Refractive Surgery.

The ALLEGRETTO WAVE® Eye-Q expands the boundaries of candidacy for LASIK. However, there are certain people who are less than ideal candidates for LASIK and ALLEGRETTO WAVE® Eye-Q treatment. You are encouraged to speak with your doctor to find the best vision correction alternative if:

LASIK is also not recommended for patients with:

During the consultation with your doctor, please be sure to mention all medications you are taking and any medical conditions you have that might affect the success of laser correction.

Click below to view the PDF of the complete ALLEGRETTO WAVE® Eye-Q clinical results for Myopia and Hyperopia .

For information regarding the risks and benefits associated with the ALLEGRETTO WAVE® Eye-Q treatment, please visit www.allegretto-wave.com or www.fda.gov.

Back to top